Literature DB >> 9190022

Mycoplasma bovis as an agent of mastitis, pneumonia, arthritis and genital disorders in cattle.

H Pfützner1, K Sachse.   

Abstract

Bovine diseases due to Mycoplasma bovis can cause considerable economic losses in cattle production. While the pathogen is principally responsible for therapy-resistant mastitis on large dairy farms, on smaller farms the typical mycoplasma diseases are calf pneumonia and arthritis. Moreover, the pathogen is able to cause genital disorders. M. bovis infection can be controlled effectively only if appropriate measures are implemented at the earliest possible stage. Since immunoprophylaxis and antibiotic treatment are known to be ineffective, control measures must include the introduction of strict hygiene standards, the restriction of animal movement out of infected herds and the culling of clinically diseased animals and shedders of the mycoplasma (the latter only in the case of mastitis and genital disorders). In this review, symptoms of the various diseases caused by M. bovis are described and characteristics of the course of infection are outlined. To clarify the origin and spread of the infection, the authors describe the main properties and reservoirs of the pathogen and summarise experimental evidence on modes of transmission to susceptible organs. As effective diagnosis is a prerequisite for the introduction of early control measures, the advantages and disadvantages of currently used diagnostic methods are discussed in detail. It is a serious shortcoming if testing for mycoplasmas is not included in routine bacterial examination of clinical samples. As a consequence, some M. bovis infections will remain undetected and outbreaks cannot be controlled properly. Finally, practical recommendations are given for prevention and control, including the formation of mycoplasma-free herds.

Entities:  

Mesh:

Year:  1996        PMID: 9190022     DOI: 10.20506/rst.15.4.987

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  47 in total

1.  The vsp locus of Mycoplasma bovis: gene organization and structural features.

Authors:  I Lysnyansky; K Sachse; R Rosenbusch; S Levisohn; D Yogev
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae.

Authors:  M D Glew; L Papazisi; F Poumarat; D Bergonier; R Rosengarten; C Citti
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Extended repertoire of genes encoding variable surface lipoproteins in Mycoplasma bovis strains.

Authors:  Sarit Nussbaum; Inessa Lysnyansky; Konrad Sachse; Sharon Levisohn; David Yogev
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Juxtaposition of an active promoter to vsp genes via site-specific DNA inversions generates antigenic variation in Mycoplasma bovis.

Authors:  I Lysnyansky; Y Ron; D Yogev
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

5.  Cell surface antigens of Mycoplasma species bovine group 7 bind to and activate plasminogen.

Authors:  Kylie Bower; Steven P Djordjevic; Nicholas M Andronicos; Marie Ranson
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Variable lipoprotein genes of Mycoplasma agalactiae are activated in vivo by promoter addition via site-specific DNA inversions.

Authors:  Ravenna Flitman-Tene; Sigalit Mudahi-Orenstein; Sharon Levisohn; David Yogev
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

7.  Identification and serological specificity of a polysaccharide component from Mycoplasma bovis.

Authors:  B W Brooks; C L Lutze-Wallace; P Lu; R H Robertson
Journal:  Vet Res Commun       Date:  2004-04       Impact factor: 2.459

8.  Molecular epidemiological analysis of Mycoplasma bovis isolates from the United Kingdom shows two genetically distinct clusters.

Authors:  Laura McAuliffe; Branko Kokotovic; Roger D Ayling; Robin A J Nicholas
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins.

Authors:  K Sachse; J H Helbig; I Lysnyansky; C Grajetzki; W Müller; E Jacobs; D Yogev
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

10.  Therapeutic Chlamydophila abortus and C. pecorum vaccination transiently reduces bovine mastitis associated with Chlamydophila infection.

Authors:  Carolin Biesenkamp-Uhe; Yihang Li; Hans-Robert Hehnen; Konrad Sachse; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.